Complete Prescribing Information and Medication Guide for ADVAIR DISKUS
Important Safety Information About ADVAIR DISKUS 250/50
ADVAIR DISKUS 250/50 is approved for adults with COPD, including chronic bronchitis, emphysema, or both. You should only take 1 inhalation of ADVAIR twice a day. Higher doses will not provide additional benefits. People with COPD taking ADVAIR may have a higher chance of pneumonia. Call your doctor if you notice any of the following symptoms: change in amount or color of sputum, fever, chills, increased cough, or increased breathing problems. CONTINUED BELOW
Notice to Patients with Asthma
FDA has updated its recommendations for the appropriate use of asthma medications containing long-acting beta-agonists (LABAs), such as ADVAIR.
We are currently updating the site to include these recommendations from FDA.
Please click here for recent information from the FDA.
Click here for the updated Prescribing Information and Medication Guide.
Note: The new recommendations do not apply to the use of LABAs for the treatment of COPD.
An estimated 24 million adults in the United States have COPD. ADVAIR helps significantly improve lung function for better breathing.†
Get your first full prescription of ADVAIR free*
Important Safety Information About ADVAIR DISKUS 250/50 for COPD
ADVAIR DISKUS 250/50 is approved for adults with COPD, including chronic bronchitis, emphysema, or both. You should only take 1 inhalation of ADVAIR twice a day. Higher doses will not provide additional benefits. People with COPD taking ADVAIR may have a higher chance of pneumonia. Call your doctor if you notice any of the following symptoms: change in amount or color of sputum, fever, chills, increased cough, or increased breathing problems.
ADVAIR may increase your risk of osteoporosis and some eye problems (cataracts or glaucoma). You should have regular eye exams. Thrush in the mouth and throat may occur. Tell your doctor if you have a heart condition or high blood pressure before taking ADVAIR. Do not use ADVAIR with long-acting beta2-agonists for any reason. ADVAIR does not replace fast-acting inhalers for sudden symptoms.
*Subject to eligibility. Restrictions apply.
†ADVAIR 250/50 is clinically proven to significantly improve lung function (measured by a breathing test), compared with people taking either fluticasone propionate 250 mcg or salmeterol 50 mcg (inhalation powders). Your results may vary.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This website is funded and developed by GlaxoSmithKline.
This site is intended for US residents only.
© 1997-2010 GlaxoSmithKline. All Rights Reserved.
Legal Notices | Privacy Statement | Medicine Savings | Contact Us